These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 37520557)

  • 1. Intravesical BCG in bladder cancer induces innate immune responses against SARS-CoV-2.
    Pichler R; Diem G; Hackl H; Koutník J; Mertens LS; D Andrea D; Pradere B; Soria F; Mari A; Laukhtina E; Krajewski W; Teoh JY; Del Guidice F; Moschini M; Thurnher M; Posch W
    Front Immunol; 2023; 14():1202157. PubMed ID: 37520557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections.
    van Puffelen JH; Novakovic B; van Emst L; Kooper D; Zuiverloon TCM; Oldenhof UTH; Witjes JA; Galesloot TE; Vrieling A; Aben KKH; Kiemeney LALM; Oosterwijk E; Netea MG; Boormans JL; van der Heijden AG; Joosten LAB; Vermeulen SH
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36693678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
    White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
    Front Immunol; 2021; 12():801799. PubMed ID: 35222355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of different Bacillus Calmette-Guerin substrains on growth inhibition of T24 bladder cancer cells and cytokines secretion by BCG activated peripheral blood mononuclear cells of PBMCs.
    Janaszek-Seydlitz W; Prygiel M; Bucholc B; Wiatrzyk A; Czajka U; Górska P; Soliwoda U
    Adv Clin Exp Med; 2014; 23(6):877-84. PubMed ID: 25618112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-muscle invasive bladder cancer: a randomized, double-blind study.
    Ji N; Mukherjee N; Reyes RM; Gelfond J; Javors M; Meeks JJ; McConkey DJ; Shu ZJ; Ramamurthy C; Dennett R; Curiel TJ; Svatek RS
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33653802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCG activation of trained immunity is associated with induction of cross reactive COVID-19 antibodies in a BCG vaccinated population.
    Iqbal NT; Ahmed K; Sattar T; Aziz F; Hussain R
    PLoS One; 2024; 19(5):e0302722. PubMed ID: 38722827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
    Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can BCG vaccine protect against COVID-19 via trained immunity and tolerogenesis?
    Basak P; Sachdeva N; Dayal D
    Bioessays; 2021 Mar; 43(3):e2000200. PubMed ID: 33169410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of innate training in bovine γδ T cells following subcutaneous BCG administration.
    Samuel BER; Diaz FE; Maina TW; Corbett RJ; Tuggle CK; McGill JL
    Front Immunol; 2024; 15():1423843. PubMed ID: 39100669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle-Invasive Bladder Cancer Patients.
    Derré L; Cesson V; Lucca I; Cerantola Y; Valerio M; Fritschi U; Vlamopoulos Y; Burruni R; Legris AS; Dartiguenave F; Gharbi D; Martin V; Vaucher L; Speiser DE; Romero P; Jichlinski P; Nardelli-Haefliger D
    Clin Cancer Res; 2017 Feb; 23(3):717-725. PubMed ID: 27521445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults.
    Rakshit S; Adiga V; Ahmed A; Parthiban C; Chetan Kumar N; Dwarkanath P; Shivalingaiah S; Rao S; D'Souza G; Dias M; Maguire TJA; Doores KJ; Zoodsma M; Geckin B; Dasgupta P; Babji S; van Meijgaarden KE; Joosten SA; Ottenhoff THM; Li Y; Netea MG; Stuart KD; De Rosa SC; McElrath MJ; Vyakarnam A
    Front Immunol; 2022; 13():985938. PubMed ID: 36268023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 infection threat in patients with high-risk non-muscle invasive bladder cancer receiving intravesical BCG therapy.
    Akan S; Ediz C; Kızılkan YE; Alcin A; Tavukcu HH; Yilmaz O
    Int J Clin Pract; 2021 Mar; 75(3):e13752. PubMed ID: 33064918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCG vaccination provides protection against IAV but not SARS-CoV-2.
    Kaufmann E; Khan N; Tran KA; Ulndreaj A; Pernet E; Fontes G; Lupien A; Desmeules P; McIntosh F; Abow A; Moorlag SJCFM; Debisarun P; Mossman K; Banerjee A; Karo-Atar D; Sadeghi M; Mubareka S; Vinh DC; King IL; Robbins CS; Behr MA; Netea MG; Joubert P; Divangahi M
    Cell Rep; 2022 Mar; 38(10):110502. PubMed ID: 35235831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer.
    van Puffelen JH; Keating ST; Oosterwijk E; van der Heijden AG; Netea MG; Joosten LAB; Vermeulen SH
    Nat Rev Urol; 2020 Sep; 17(9):513-525. PubMed ID: 32678343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG).
    Saban MR; Simpson C; Davis C; Wallis G; Knowlton N; Frank MB; Centola M; Gallucci RM; Saban R
    BMC Immunol; 2007 May; 8():6. PubMed ID: 17506885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent memory despite rapid contraction of circulating T Cell responses to SARS-CoV-2 mRNA vaccination.
    Taus E; Hofmann C; Ibarrondo FJ; Gong LS; Hausner MA; Fulcher JA; Krogstad P; Kitchen SG; Ferbas KG; Tobin NH; Rimoin AW; Aldrovandi GM; Yang OO
    Front Immunol; 2023; 14():1100594. PubMed ID: 36860850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive Immune Resistance to Intravesical BCG in Non-Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials.
    Kates M; Matoso A; Choi W; Baras AS; Daniels MJ; Lombardo K; Brant A; Mikkilineni N; McConkey DJ; Kamat AM; Svatek RS; Porten SP; Meeks JJ; Lerner SP; Dinney CP; Black PC; McKiernan JM; Anderson C; Drake CG; Bivalacqua TJ
    Clin Cancer Res; 2020 Feb; 26(4):882-891. PubMed ID: 31712383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacillus Calmette-Guérin-induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 mice.
    Zhang BZ; Shuai H; Gong HR; Hu JC; Yan B; Yuen TT; Hu YF; Yoon C; Wang XL; Hou Y; Lin X; Huang X; Li R; Au-Yeung YM; Li W; Hu B; Chai Y; Yue M; Cai JP; Ling GS; Hung IF; Yuen KY; Chan JF; Huang JD; Chu H
    JCI Insight; 2022 Jun; 7(11):. PubMed ID: 35446790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [BCG, muramylpeptides, trained immunity (part I): linkages in the light of the COVID-19 pandemic].
    Kalyuzhin OV; Andronova TM; Karaulov AV
    Ter Arkh; 2020 Dec; 92(12):195-200. PubMed ID: 33720594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-depth analysis of T cell immunity and antibody responses in heterologous prime-boost-boost vaccine regimens against SARS-CoV-2 and Omicron variant.
    Heinen N; Marheinecke CS; Bessen C; Blazquez-Navarro A; Roch T; Stervbo U; Anft M; Plaza-Sirvent C; Busse S; Klöhn M; Schrader J; Vidal Blanco E; Urlaub D; Watzl C; Hoffmann M; Pöhlmann S; Tenbusch M; Steinmann E; Todt D; Hagenbeck C; Zimmer G; Schmidt WE; Quast DR; Babel N; Schmitz I; Pfänder S
    Front Immunol; 2022; 13():1062210. PubMed ID: 36618413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.